| APVO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the APVO shares outstanding history going back to 8/1/2016:
Also see: APVO Market Cap History APVO YTD Return |
APVO Shares Outstanding History — Aptevo Therapeutics Share Count Over Time
As of 5/13/2026 Aptevo Therapeutics has 1.25 million APVO shares outstanding. Investors often track the APVO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows APVO share count trends over time, with 42 historical shares outstanding datapoints presented, dating back to 8/1/2016.
| APVO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
APVO Historical Shares Outstanding: +290.94% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| APVO Stock Price Chart |
| About Aptevo Therapeutics Inc |
| Aptevo Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. It has developed two versatile and enabling platform technologies for rational design of precision immune modulatory drugs. Its lead clinical candidates, APVO436 and ALG.APV-527, and preclinical candidates, APVO603 and APVO711, are developed using its ADAPTIR modular protein technology platform. Its preclinical candidate APVO442 is developed using its ADAPTIR-FLEX modular protein technology platform. We show 42 historical shares outstanding datapoints in our coverage of APVO's shares outstanding history. Understanding the changing numbers of APVO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like APVO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching APVO by allowing them to research APVO shares outstanding history as well as any other stock in our coverage universe. |
| APVO Current Stock Quote |
Quotes delayed 20 minutes  Free APVO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| APVO Share Performance |
| Shares Outstanding Peers |
| Aptevo Therapeutics (APVO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
APYX Shares Outstanding History AQST Shares Outstanding History AQXP Shares Outstanding History ARA Shares Outstanding History ARAV Shares Outstanding History ARAY Shares Outstanding History ARCT Shares Outstanding History ARDM Shares Outstanding History ARDS Shares Outstanding History ARDT Shares Outstanding History More Healthcare companies » |
APVO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
